Sai Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. Un-audited Financial Results ....
RESULTS
◆ Monitor Closely
LOW RISK
📅 Filed on BSE: 04 Aug 2026, 05:16 PM IST · BSE ID: cc3f0e20-5b66-48c2-b1bc-4d43325ac5da
View Original BSE Filing (PDF)
💡
In Simple Terms
Sai Parenterals' board will meet on August 11, 2026, to review its financial performance for the quarter ending June 30, 2026.
🤖 AI Summary
- Sai Parenterals Board of Directors meeting scheduled for Tuesday, August 11, 2026.
- Meeting agenda includes considering un-audited financial results for quarter ended June 30, 2026.
- Both Standalone and Consolidated financial results will be presented for review and approval.
- A Limited Review Report for the June 30, 2026 quarter (Standalone and Consolidated) is also on the agenda.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any action based on this specific intimation.
👤
Who Is Affected
All shareholders are equally affected as the upcoming Board Meeting will determine the release of the company's financial performance data for the quarter ended June 30, 2026.
🔍
Management Signal
This intimation indicates management's commitment to fulfilling regulatory obligations by scheduling the disclosure of quarterly financial results.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Release of Un-audited Financial Results for Q1 FY27 (June 30, 2026).
Analysis of Standalone and Consolidated results for revenue and profit trends.
Details of the Limited Review Report from the Board Meeting on August 11, 2026.
LOW RISK
This filing is a routine announcement of a board meeting for results approval, carrying minimal inherent risk.
💡 Investor Takeaway
Sai Parenterals Ltd. has scheduled a Board Meeting for August 11, 2026, to consider and approve its un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, alongside the Limited Review Report.
📅 Company Track Record
Sai Parenterals was recently listed via an IPO in March 2026. The company requested a 23-day extension to file its Q3 FY26 results (due April 22, 2026) citing audit delays for an acquired Australian subsidiary, indicating a limited public track record.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
When is the Board Meeting of Sai Parenterals Ltd. scheduled?
The Board Meeting of Sai Parenterals Ltd. is scheduled for Tuesday, August 11, 2026.
What financial results will be considered at the Sai Parenterals Board Meeting?
The Board Meeting will consider the Un-audited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026.
What additional report will the Sai Parenterals Board review?
The Board will also consider the Limited Review Report (Standalone and Consolidated) for the quarter ended June 30, 2026.
Questions based on this BSE filing only. For information purposes.